Clean area

Who is novosanis

Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests as well as the accuracy of drug delivery for infectious diseases and oncology.

Colli Pee Novosanis

Improving the quality of diagnostics by volumetric self-sampling of first-void (first catch) urine

Colli-Pee in a box

Improving the quality of home-based urine collection by easy self-sampling, alongside postal packaging

Latest news

CE-IVD marked

Colli-Pee® Small Volumes Products CE Marked

Novosanis achieved two major milestones - our Colli-Pee ® Small Volumes product line is now CE-Marked.

Latest blogpost

blog impact covid-19 on cervical cancer screening
Cancer screening rates have significantly dropped due to the COVID-19 pandemic. Alternative sampling methods are essential to continue healthcare practices in these challenging times. Urine as a sample type has shown great potential especially for cervical cancer screening

Upcoming event

Eurogin 2021

Eurogin 2021

Düsseldorf, Germany
Novosanis is excited to have a booth at EUROGIN, an international conference focusing on Human Papillomavirus (HPV). We look forward to speaking with you and discussing the potential of urine sampling in HPV detection through our innovative medical device, Colli-Pee.